Elanco Animal Health Inc

Founded in 1954 as a division of Eli Lilly and Company, the headquarters of this now-independent entity since 2018 is nestled in Greenfield, Indiana, United States. The company is a key player in the animal health industry with a focus on various business segments, notably Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. Its portfolio includes prominent brands such as Credelio, Interceptor, Trifexis, Atopica, Osurnia, Capstar, and Galliprant, each playing a significant role in their respective categories. With operations that extend across the globe, the company has a diverse reach in markets including the United States, Canada, across Europe, as well as in Australia, Brazil, China, and Japan. While these countries represent key markets, the company's impact is felt across over 90 countries. It is important to note that the importance of each country to the company's bottom line may shift depending on market conditions and strategic priorities. (Powered by AI)